Mein Warenkorb

CD200 R1

CD200 R1 Molekülinformation

Englischer NameCell surface glycoprotein CD200 receptor 1Anzahl der inverkehr gebrachten Arzneimittel0
Anzahl der klinischen Arzneimittel4Target-AliasCell surface glycoprotein OX2 receptor 1,CD200 cell surface glycoprotein receptor,CD200R
Höchste Forschungs- und EntwicklungsphasePhase 2 Clinical
Englischer NameCell surface glycoprotein CD200 receptor 1
Target-AliasCell surface glycoprotein OX2 receptor 1,CD200 cell surface glycoprotein receptor,CD200R
Anzahl der inverkehr gebrachten Arzneimittel0
Anzahl der klinischen Arzneimittel4
Höchste Forschungs- und EntwicklungsphasePhase 2 Clinical

CD200 R1 Produktliste

  • Attribut

    Protein (2)

  • Produktbibliothek

    Online (2)

  • Spezies

    Human (2)

  • Etikett

    Fc Tag & Avi Tag (1)His Tag (1)

  • Marker

    Biotin-labeled (1)Unconjugated (1)

ProduktnummerSpeziesExpressionssystemProduktbeschreibungProteinstrukturReinheitEigenschaftenVorbestellen/Bestellen
Human
HEK293
Human CD200 R1 / CRTR2 Protein, His Tag, low endotoxin (MALS verified)
In den Warenkorb legen
Human
HEK293
Biotinylated Human CD200 R1 / CRTR2 Protein, Fc,Avitag™
In den Warenkorb legen
Gesamtmenge2
  • 1

CD200 R1 Molekülhintergrund

Cell surface glycoprotein CD200 receptor 1 is a protein that in humans is encoded by the CD200R1 gene. This gene encodes a receptor for the OX-2 membrane glycoprotein. Both the receptor and substrate are cell surface glycoproteins containing two immunoglobulin-like domains. This receptor is restricted to the surfaces of myeloid lineage cells and the receptor-substrate interaction may function as a myeloid downregulatory signal. CD200 and its receptor CD200R are both type-1 membrane glycoproteins, which are members of the immunoglobulin superfamily (IgSF). Besides the inhibitory effect on macrophages, CD200/CD200R also play an important role in regulating the regulatory T cells, allergicreaction, autoimmune diseases, allograft, neurological diseases and other autoimmune-related diseases. The interaction between CD200, which is mainly present in neurons but also in astrocytes, and CD200R1, which is mainly present in microglia, is one of the mechanisms involved in keeping the microglial proinflammatory phenotype under control in physiological conditions. Alterations in the expression of CD200 and CD200R1 have been described in neurodegenerative diseases, but little is known about the mechanism of regulation of these proteins under physiological or pathological conditions.

CD200 R1 Molekülalias

CD200R,CRTR2,MOX2R,OX2R

Lizenzierungszusammenarbeit

ProjektnameArzneimitteltypTherapiegebietIndikationenStufeRechtsgebiet
High selective OX1R/OX2R dual inhibitor treating insomniaSmall moleculeNeurological diseaseInsomniaPhase IGlobal

Klinische Arzneimittelinformation

Englischer NameForschungscodeForschungsphaseFirmaIndikationenKlinische Studie
P-00623ME-00610; P-006; 23ME’610Phase 2 Clinical23andme IncCarcinoma, Ovarian Epithelial; Carcinoma, Renal Cell; Fallopian Tube Neoplasms; Microsatellite instability-high cancer; Neuroendocrine Tumors; Peritoneal Neoplasms; Small Cell Lung Carcinoma; Solid tumours
Details
GS-5305GS-5305Phase 1 ClinicalGilead Sciences LdaInflammation
Details
DS-234DS-234; ARQ-234Phase 1 ClinicalDucentis BioTherapeutics LtdDermatitis, Atopic; Eczema
Details
UcenprubartLY-3454738Phase 1 ClinicalEli Lilly And CompanyChronic Urticaria; Dermatitis, Atopic
Details
  • Molekülinformation
  • Produktliste
  • Klinische Arzneimittelinformation
Kontaktieren Sie uns